logo
After Mattewara textile park, now Punjab villagers up in arms against cement plant project

After Mattewara textile park, now Punjab villagers up in arms against cement plant project

Indian Express4 days ago
'Punjab should promote tourism, non-polluting industry to preserve its air, water, and fertile land,' cried the villagers of Talwandi Aklia, who are up in arms against the proposal of setting up a cement plant in Mansa district.
The villagers have outrightly voted against the proposal at a public hearing committee meeting held on July 14 at Talwandi Aklia in which the representatives of the cement plant, Punjab Pollution Control Board (PPCB) officials, Mansa district administration officials, residents of nearly 20 villages of Mansa and members of the public action committee (PAC) from across the state had participated.
JSW Cement is to set up a high-capacity cement manufacturing unit with an estimated production capacity of six million tonnes per annum (MTPA) on 19 hectares of land covering Talwandi Aklia and neighbouring Karamgarh Autanwali villages. The company has already acquired around 67 acres of land. According to villagers, nearly 40 acres have been sold to the cement company by a US-based NRI who hasn't visited Punjab for years.
'A majority of the villagers voted against the proposal to set up this cement plant. Now let's see what happens next. We will stay alert, and if the project gets environmental clearance from the Punjab government despite our stiff resistance, we will start agitation against it. They can set up agro-based projects, cotton mills, etc. But why a cement plant?' asked Manpreet Singh Aklia, an activist of Talwandi Sabo Morcha set up to fight against the project. He is a farmer from Aklia village of Mansa.
According to sources, the cement company will be setting up two production units and an additional grinding unit.
The public hearing on the project's environmental impact was organised by the Punjab Pollution Control Board (PPCB). It was attended by hundreds of local villagers, farmers, and activists under the banner of the newly formed 'Talwandi Morcha'.
'We fear for our future,' said Manpreet Singh, a farmer from Talwandi Aklia who participated in the hearing. 'Such large-scale red-category industries bring pollution and health hazards. Our fields, air, and water will all suffer,' he said.
Already there is one thermal power plant in Banawali village of Mansa located nearby and the villagers said they can't afford to have another polluting unit.
'Villagers raised alarm over the plant's categorisation as a 'red-category' industry — a classification reserved for industrial units that pose a significant risk of pollution. They argue that cement dust emissions and possible contamination of groundwater could jeopardise agriculture, the mainstay of the local economy,' said Jaskirat Singh, a member of PAC.
Local youth and women, too, have joined the campaign, holding awareness meetings and door-to-door campaigns to rally more villagers, said Kapil Arora, another PAC member.
Villagers feared that apart from air and water pollution, the unit will also damage the roads of villages after hundreds of cement-laden trucks and many trucks carrying fly ash from Banawali thermal power plant to be used as raw material in the cement factory will cross the roads quite often.
Representatives of JSW Cement and district officials tried to allay fears during the hearing, promising strict adherence to environmental norms and highlighting possible job opportunities for local people. However, villagers remain unconvinced, pointing to past examples where job promises were not kept.
The final nod for the plant will depend on environmental clearances at the national level under the Environment Impact Assessment (EIA) Notification 2006. Meanwhile, local resistance is likely to intensify in the coming weeks, with the Talwandi Morcha planning further meetings, legal consultations, and protests.
'The conflict underlines the delicate balance between industrial expansion and community rights in Punjab's agrarian belt, where farmers already face mounting challenges related to land use, groundwater depletion, and pollution,' said Jaskirat Singh.
The PAC had previously mobilised strong opposition to the Ruchira Paper Mill project near Chamkaur Sahib, with its public hearing held on April 30. During this hearing, residents from around 50 villages, backed by PAC activists, raised urgent concerns about the mill's proximity — just 10 metres —to Buddha Dariya and about 200 m from the Neelon Canal, both key water sources. Out of 873 attendees, 853 opposed the project, citing risk of severe water contamination in an ecologically vulnerable zone.
Similarly, in January–July 2022, PAC led a campaign against the proposed Mega Textile Park at Mattewara in Ludhiana voicing fears over threats to the Sutlej river ecosystem and local forests. That sustained activism led to the Punjab government cancelling the project in July 2022.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Staff shortage in DICs hits promotion of MSME schemes
Staff shortage in DICs hits promotion of MSME schemes

Time of India

time29 minutes ago

  • Time of India

Staff shortage in DICs hits promotion of MSME schemes

1 2 Koraput: Staff shortage in the District Industries Centre (DIC), Koraput, is affecting the implementation of govt schemes and outreach activities meant to boost entrepreneurship among unemployed youth. Official data revealed that 10 out of 14 sanctioned posts of assistant industries officers (AIOs) are vacant, severely limiting operations. Ideally, every block is supposed to have at least one AIO to raise awareness about various govt schemes aimed at promoting micro, small and medium enterprises (MSMEs). However, only four posts are filled currently, with one officer managing multiple blocks simultaneously. Most of their time is spent at the district office occupied with official work. The shortage has hampered field-level engagement and awareness drives. The impact of the administrative vacuum shows as only two persons applied for capital subsidies under MSME schemes this year — an alarmingly low number that experts attributed to poor information dissemination and lack of guidance from field officials. "This is in stark contrast to the govt's emphasis on promoting self-employment and MSMEs among youth in tribal and rural belts like Koraput. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Up to 70% off | Shop Sale Libas Undo AIOs are key personnel in promoting and implementing the govt schemes. But with most of the posts lying vacant, the efforts are falling short," said Ajit Pata, a Koraput-based activist. Two posts of assistant managers are also lying vacant in the DIC, creating bottlenecks in the implementation and monitoring of schemes. "There is certainly a shortage of staff, and it has affected scheme implementation to some extent," said general manager of DIC (Koraput), Chinmayee Parida. "However, we are doing our best with the limited resources. We are hopeful that additional staff will be recruited by Oct," he added. "Unless the vacancies are urgently filled, many potential entrepreneurs may continue to miss out on vital govt support. The gap between policy intent and ground-level execution has to be resolved soon to strengthen the DIC's field presence," said Bhabani Mishra, another activist.

Brookfield, EQT Close In on Gland Pharma, but Rising Stock a Pain
Brookfield, EQT Close In on Gland Pharma, but Rising Stock a Pain

Time of India

time44 minutes ago

  • Time of India

Brookfield, EQT Close In on Gland Pharma, but Rising Stock a Pain

Live Events Buyout groups Brookfield and EQT are in active discussions to buy Hyderabad-based Gland Pharma, a contract development and manufacturing organisation (CDMO) and injectables company, from China's Fosun Group in what could become one of the largest buyouts of the year in the segment, said people in the know. However, the galloping share price of Gland is a potential deal two private equity groups have been shortlisted after the initial round of bids earlier this such as CVC Capital Partners are also exploring a deal, said the people cited. Warburg Pincus is said to be weighing its options before taking a call, they Chinese parent has diversified investments that range from healthcare to football clubs, asset management, banks, estate, hospitality, fashion and industrials. The conglomerate has a presence across the pharma value chain from manufacturing to diagnostics and medical devices. Shanghai Fosun Pharmaceutical Co. had acquired an 86% stake in Gland Pharma in 2016 from KKR for a record deal value of $1.26 currently owns 51.8% of Gland, having pared its stake over the years. Market capitalisation has shot up to Rs 32,964.47 crore with the Gland Pharma stock appreciating 10% in the year to date in anticipation of a transaction. It closed Friday at Rs 2,000. In the past month alone, it has shot up 16%. The Fosun stake alone would require a payout of Rs 17,141.28 crore ($1.9 billion).Change of control will involve an open offer for an additional 26% of the company from minority shareholders, making it a much larger transaction. If the open offer is fully subscribed, it would translate to a Rs 25,711 crore ($3 billion) acquisition at current and Gland didn't respond to queries. Brookfield and EQT declined to investors are of the view the stock is overpriced and are interested only at a discount to the current level. 'There are macro headwinds because of industry glut and geopolitics,' said one of the people cited. 'Fosun has to decide if it is okay to sell at a significantly lower price.'This factor could be a deal breaker, analysts said. 'At this level, the process looks tough,' said another industry official. Fosun at various times in recent years, renewed its search for a strategic or financial deal for Gland Pharma. The company ran a full sale process last year but aborted it, only to revive plans earlier this summer, mandating Morgan Stanley and UBS. Mint was first to report that PE interest in Gland had revived in in 1978 by PVN Raju, Gland Pharma develops and manufactures generic injectables for use in nearly 90 countries on five continents, with a focus on the Indian and US markets. As with other Chinese companies, Fosun has faced regulatory issues in India due to the frosty relationship between the two countries. Even its entry into India faced significant delays with deal contours needing tweaks to comply with FDI norms. Some experts said Fosun sees the timing as ideal for an exit. But with no success for years, Fosun has been selling down its shares in the public markets through block deals. Last year, it sold about 6% for ₹1,750 crore. 'The incremental growth for the company's base business in the US is likely to come at the cost of margins,' said Shyam Srinivasan of Goldman management is expecting Cenexi Group — a French injectables and CDMO company Gland acquired in 2023 — to break even by the December quarter. Gland has a toehold in Europe through Cenexi, but rebooting the organisation and its product mix has been analysts said Gland has a sound track record and its future prospects may attract buyers.A veteran industry expert said Gland Pharma has a 'strong compliance history' and its manufacturing quality is impeccable. Plus, a surge in demand is seen for large injectable capacities across the world, making it a good fit. Another strong push for Gland Pharma is the explosive growth in glucagon-like peptide-1(GLP-1) drugs for weight loss and diabetes. Novo Nordisk's Wegovy (semaglutide) is set to go off patent early next year in India and Canada, leading to a burst of generic variants expected to enter the market. This is likely to offset the current overcapacity of injectable assets around the world. Trade tensions between the US and China are adding to the interest in Indian contract manufacturing players for steady supplies. 'Although we have not seen any meaningful switching from China yet, such opportunities cannot be ruled out in the future,' an industry executive is also preparing for a larger play in the biologics business, focusing on expanding its biosimilar and biologic CDMO segment.'The company's collaboration with DRL (Dr Reddy's) and discussions with Henlius (of China) are progressing well, with revenue generation from DRL business expected from FY26,' it said in the presentation.

Viceroy calls semiconductor unit of Vedanta a 'sham op'
Viceroy calls semiconductor unit of Vedanta a 'sham op'

Time of India

timean hour ago

  • Time of India

Viceroy calls semiconductor unit of Vedanta a 'sham op'

Vedanta NEW DELHI: Continuing its tirade against mining heavyweight Anil Agarwal 's Vedanta group, US-based Viceroy Research has alleged that the group's semiconductor unit was a "sham commodities trading operation", designed to avoid classification as an NBFC, a charge the conglomerate called baseless. The short seller, which last week published a scathing report about Vedanta Group and followed it up with similar reports on group companies, in fresh allegations said Vedanta Ltd's subsidiary, Vedanta Semiconductors Pvt Ltd, was part of a scheme to allow the Mumbai-listed firm to remit brand fees to parent Vedanta Resources in April this year, when it faced a severe liquidity crisis. In a statement, Vedanta spokesperson said the group "strongly rejects the baseless allegations made in the report regarding Vedanta Semiconductors Pvt Ltd (VSPL)". "All business activities of VSPL have been transparently disclosed and are in line with statutory norms," it said. Viceroy said, "VSPL is a sham commodities trading operation designed to improperly avoid classification as a Non-Banking Financial Company (NBFC)". "This scheme was devised to facilitate Vedanta Ltd's remittance of brand fees to Vedanta Resources' (VRL) in April 2025, when it faced a severe liquidity crisis," Viceroy said. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like American Investor Warren Buffett Recommends: 5 Books For Turning Your Life Around Blinkist: Warren Buffett's Reading List Undo "VSPL's operational illusion needs 24 months of regulatory silence to fulfil its purpose, repaying its offshore lenders and hiding the near-catastrophe of April 2024. While credit analysts are snoozing through the alarm bells, India's regulators are famously light sleepers," it added. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store